A new worldwide study shows women with blocked heart arteries are good candidates for treatment with drug-eluting stents. Presented today in a Clinical Trial Update Hot Line Session at the ESC Congress 2013 (European Society of Cardiology) and simultaneously published in The Lancet, the study provides critical information on the treatment of women, who are historically underrepresented in clinical trials.

The OB/GYN patient screening pilot program launched by SCAI-Women in Innovations (“WIN”) and Abbott Vascular’s Women’s Heart Health Initiative made huge strides in 2012, as impressive early results were presented at medical meetings across the United States and journalists picked up the story.